Currently in phase 3 trials, Roluperidone has shown efficacy in improving global functioning in schizophrenia, and based on the data, Dr. Strauss reported that these global improvements were mediated by Roluperidone’s ability to reduce avolition
As far as I know Roluperidone has been rejected by the FDA.
Yes, roluperidone approval was denied. The drug would need a new trial, that might not happen.
Whats the point in making new meds
Yea precisely , just take clozapine and you sure will live a very fruitful life
Newer meds often have lower side effects.
Like electronics or any technology - they improve over time as our understanding of them grows.
Ah now I understand